An observational study in Chromosomal Aneuploidies and Single Gene Desease, sponsored by Cervesi Hospital, Cattolica, Italy. Status unknown at 1 site in Italy. Open to female participants aged 18 Years to 40 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2021-02-09.
Sponsored by Cervesi Hospital, Cattolica, Italy · Observational
The objective will focus on the characterization of DNA fragments present in Blastocoele fluid, and the evaluation of these fragments as potential target for Preimplantation Genetic Diagnosis. To reach this goal, real-time PCR, Whole Genome Amplification techniques and -subsequently- Next Generation Sequencing and aCGH approaches will be used.
IVF patient with supernumerary embryos to vitrify at blastocyst stage
Exclusion Criteria:
all the patients that have supernumerary embryos to vitrify at blastocyst stage
Other: blastocoele aspiration
Number of samples with DNA in blastocoele Fluid
the presence of DNA will be evaluated through rtPCR
Time frame: 6 month
Number of euploid samples
Array CGH
Time frame: 8 months
This study is status unknown, as verified in Feb 2021. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Cervesi Hospital, Cattolica, Italy